2017
DOI: 10.11138/gchir/2017.38.2.077
|View full text |Cite
|
Sign up to set email alerts
|

Bilateral primary ovarian non-Hodgkin�s lymphoma and fertility preservation: 5-year follow-up

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
4
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(4 citation statements)
references
References 8 publications
(11 reference statements)
0
4
0
Order By: Relevance
“…Vang R et al reported that patients who undergo surgery, radiation, or chemotherapy have an equitable prognosis [3]. However, other experts feel that chemotherapy combined with radiotherapy, rather than signi cant surgical resection, can provide a better prognosis, and nonsurgical treatment can help the reproductive system function properly [19,20]. In any case, combinations of different regimens are needed, and single regimens are often ineffective [21].…”
Section: Discussionmentioning
confidence: 99%
“…Vang R et al reported that patients who undergo surgery, radiation, or chemotherapy have an equitable prognosis [3]. However, other experts feel that chemotherapy combined with radiotherapy, rather than signi cant surgical resection, can provide a better prognosis, and nonsurgical treatment can help the reproductive system function properly [19,20]. In any case, combinations of different regimens are needed, and single regimens are often ineffective [21].…”
Section: Discussionmentioning
confidence: 99%
“…This is not the case for primary ovarian non-Hodgkin's lymphoma. In most publications, the median age of patients was 42 to 47 years [ 17 , 18 ], but it can occur at any age. Senol et al reported a median age of 57 years.…”
Section: Discussionmentioning
confidence: 99%
“…Other signs that have been reported include weight loss, fever, and sometimes metrorrhagia [ 9 , 14 - 15 ]. A clinical examination may find hepatosplenomegaly or palpable adenopathy [ 17 ]. In our case, the patient was diagnosed with isolated pelvic pain.…”
Section: Discussionmentioning
confidence: 99%
“…Rituximab, a monoclonal antibody against CD20, is an immunotherapeutic agent that plays an important role in the treatment of CD20-positive B-cell lymphoma, including extranodal lymphoma [16]. Grigoriadis et al have reported that rituximab may be a better choice for patients desiring to preserve their fertility [17]. As early as 2007, Signorelli M et al proposed that a conservative management based on exclusive chemotherapy at early stages of PLFGT may be attempted in patients desiring to become pregnant [18].…”
Section: Discussionmentioning
confidence: 99%